144453-51-0

2-Naphthacenecarboxaldehyde, 5,12-dihydro-5,12-dioxo-

Order [ 144453-51-0 ] Now

2,4,10,12-Tetraoxadispiro[5.1.5.3]hexadecan-7-one,3,11-bis(2-chlorophenyl)-

2(1H)-Quinoxalinone, 3-(2-fluoro-3-iodophenyl)-5-nitro-

2(1H)-Quinolinone,6-chloro-4-(2-hydroxyphenyl)-3-(3-methyl-5-isoxazolyl)-

2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-[(2-methoxyphenyl)methylene]-

Propanamide,N-[4,4-bis[4-(dimethylamino)phenyl]-6-methyl-4H-3,1-benzothiazin-2-yl]-2-methyl-

2,4,5(3H)-Pyrimidinetrione, 6-amino-, 5-(phenylhydrazone),monohydrochloride

2,4,5-Decatriene, 9-methyl-

2,4,5,7,9-Pentaazadodec-4-enethioamide,3,6,11-trimethyl-N,3,6-tris(2-methylpropyl)-8-thioxo-

2,4,10,14-Hexadecatetraene, 3,7,11,15-tetramethyl-, (2E,4E,10E)-

Dexpanthenol impurity E

2(1H)-Quinolinone,7-methoxy-4-(4-methoxyphenyl)-1-[[4-[4-(4-morpholinyl)-1-oxobutyl]phenyl]methyl]-

2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]methylene]-

2(1H)-Quinolinone,6-[[[5-(1H-benzimidazol-2-yl)-1H-pyrazol-3-yl]oxy]acetyl]-3,4-dihydro-

2(1H)-Quinolinone,5-chloro-3-(1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)-

2,4,6(1H,3H,5H)-Pyrimidinetrione, 4-[(4-nitrophenyl)hydrazone]

2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[(3,4-dimethoxyphenyl)methylene]-1-[(2-hydroxyethoxy)methyl]-

2(1H)-Quinolinone,6-chloro-4-[[3-(4-methyl-1-piperazinyl)propyl]amino]-3-[5-(4-morpholinyl)-1H-benzimidazol-2-yl]-

2(1H)-Quinolinone,7-methoxy-4-(4-methoxyphenyl)-1-(2-pyridinylmethyl)-

2(1H)-Quinoxalinone, 1-(2-bromo-2-propenyl)-7-(trifluoromethyl)-

2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(4-nitrobenzoyl)-

2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[[4-(dimethylamino)phenyl]methylene]-1-[(2-hydroxyethoxy)methyl]-

2,4,6(1H,3H,5H)-Pyrimidinetrione,5,5-diethyl-1,3-bis[4-(4-phenyl-1-piperazinyl)butyl]-, dihydrochloride

2(1H)-Quinoxalinone, 3-(2-hydroxy-2-phenylethenyl)-1-methyl-

2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-[(2,4-dimethoxyphenyl)methyl]-

2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(4-methoxybenzoyl)-1,3-dimethyl-,compd. with piperidine (1:1)

2(1H)-Quinoxalinone, 1-[(4-methylphenyl)methyl]-7-(trifluoromethyl)-

2,4,6(1H,3H,5H)-Pyrimidinetrione,4-[[4-(methylsulfonyl)phenyl]hydrazone]

2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-dimethyl-5-(3-nitrobenzoyl)-

2(1H)-Quinolinone,8-hydroxy-5-[(1R)-1-hydroxy-2-[[2-[4-[[3-(3-thienyl)phenyl]amino]phenyl]ethyl]amino]ethyl]-, trifluoroacetate (salt)

2,4,6(1H,3H,5H)-Pyrimidinetrione,1-[(2-hydroxyethoxy)methyl]-5-[(2-methyl-1H-indol-3-yl)methylene]-

2,4,6(1H,3H,5H)-Pyrimidinetrione,1-benzoyl-5-methyl-5-(phenylmethyl)-

2(1H)-Quinolinone,5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydrohydroxy-

2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-acetyl-, dihydrate

2,4,6(1H,3H,5H)-Pyrimidinetrione, 5,5-diethyl-, monopotassium salt

2(1H)-Quinoxalinone, 3,4-dihydro-1-methyl-4-[(3-nitrophenyl)sulfonyl]-

2,4,5-Pyrimidinetriamine, N,N-diethyl-6-methyl-

144453-51-0 msds

CAS No 144453-51-0 supplier

CASNo 144453-51-0 distributor

CAS # 144453-51-0 manufacturer

CAS Number 144453-51-0 safety

CAS RN 144453-51-0 wholesale

2026-10-11 Find 2-Naphthacenecarboxaldehyde, 5,12-dihydro-5,12-dioxo-,CAS No.144453-51-0,Formula:C19H10O3 in ChemicalsProvider